VTEX Form 144 shows planned 9,616-share sale and 10b5-1 trades
Rhea-AI Filing Summary
A VTEX shareholder filed a Form 144 notice indicating an intent to sell up to 9,616 shares of common stock, with an aggregate market value of $38,560.16. The sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE, and the filing notes that 103,947,244 common shares are outstanding. The seller acquired these 9,616 shares as founder shares from the issuer on 10/25/2021.
The notice also lists prior sales over the last three months under a Rule 10b5-1 trading program for MIRA LIMITED, including one transaction of 4,808 common shares on 11/10/2025 for $19,236.81. By signing the form, the seller represents that they are not aware of any undisclosed material adverse information about VTEX’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
What does the VTEX Form 144 filing disclose?
The filing discloses that a VTEX shareholder plans to sell up to 9,616 shares of common stock, with an aggregate market value of $38,560.16, through Morgan Stanley Smith Barney LLC on the NYSE.
What is the role of Morgan Stanley Smith Barney LLC in this VTEX Form 144?
Morgan Stanley Smith Barney LLC is identified as the broker handling the proposed sale of the 9,616 VTEX common shares on the NYSE.
What is the significance of Rule 10b5-1 in this VTEX Form 144 filing?
The filing references 10b5-1 sales for MIRA LIMITED, indicating that some VTEX share sales have been made under a pre-arranged trading plan designed to comply with Rule 10b5-1 under the Exchange Act.